The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2018 | UK transplantation trials network: four IMPACT trials launching in 2018
IMPACT, the UK’s first large-scale clinical trials platform for patients receiving a stem cell transplant, is launching in 2018. Here, Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, of the University of Birmingham, Birmingham, UK, discusses plans for the first year of IMPACT, with four prospective randomized trials set to be launched. Prof. Craddock covers the trials and rationale behind them, including COSI and PRO-DLI, which is the first randomized study investigating the benefit of donor lymphocytic infusions for the prevention of relapse post-HSCT in patients with high-risk myeloid malignancy. This video was recorded at the 2018 British Society for Hematology (BSH) Annual Scientific Meeting in Liverpool, UK.
